Reproductive outcome of fresh or frozen–thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support

By Imbar Tal   Kol Shahar   Lossos Francine   Bdolah Yuval   Hurwitz A.   Haimov-Kochman Ronit  

Human Reproduction, Vol. 27, Iss. 3, 2012-03 ,pp. : 753-759

Oxford University Press

Access to resources Recommend Favorite

Effect of duration of the GnRH agonists in the luteal phase in the outcome of assisted reproduction cycles

By Geber Selmo   Sampaio Marcos  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 608-610

Informa Healthcare

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite

The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates—a randomized, double-blinded, placebo-controlled trial

By Cantineau A.E.P   Cohlen B.J.   Klip H.   Heineman M.J.   Hoek A.   Lambalk C.B.   Hamilton C.J.   Van Bommel P.F.   van Dop P.A.   van der Heijden P.F.M.   de Sutter P.   D'Hooghe T.   Manger P.A.   Ombelet W.   Santema J.G.  

Human Reproduction, Vol. 26, Iss. 5, 2011-05 ,pp. : 1104-1111

Oxford University Press

Access to resources Recommend Favorite

Are GnRH antagonists comparable to agonists for use in IVF?

By Huirne J.A.   Homburg R.   Lambalk C.B.  

Human Reproduction, Vol. 22, Iss. 11, 2007-11 ,pp. : 2805-2813

Oxford University Press

Access to resources Recommend Favorite